Extra-virgin olive oil increases the resistance of LDL to oxidation more than refined olive oil in free-living men with peripheral vascular disease.
Patients with peripheral vascular disease (Fontaine stage II) are characterized by ischemia of the lower extremities, atherosclerosis and alteration of blood coagulation and fibrinolysis. A randomized, two-period, crossover design was used to compare the effects of extra-virgin (VO) and refined olive (RO) oils on plasma lipids and lipoprotein composition and LDL oxidation susceptibility in free-living men with peripheral vascular disease. The oils differed in their antioxidant profile (alpha-tocopherol: 300 vs. 200 mg/kg; phenolic compounds 800 vs. 60) and concentration but not in their fatty acid composition. Subjects were randomly assigned to two groups. The first group (n = 12) received VO with which to freely cook all meals for 3 mo, followed by a 3-mo wash-out period; they then received RO for the final 3 mo. The second group (n = 12) consumed the oils in the opposite order. Energy, fat, polyunsaturated fatty acids (PUFA) and alpha-tocopherol intakes were not different when patients consumed the two oils. Profiles of the major fatty acids in plasma and LDL were not different after consumption of VO and RO. The slope of the line for LDL oxidation vs. the line for copper concentration was significantly higher after the intake of RO than after the intake of VO. Total LDL taken up by macrophages was significantly greater when the men consumed RO rather than VO. We suggest that antioxidants present in VO may protect LDL against oxidation more than does RO in men with peripheral vascular disease.
Ramirez-Tortosa
M C
MC
Institute of Nutrition and Food Technology, Department of Biochemistry and Molecular Biology, Faculty of Pharmacy, University of Granada, Spain.
Urbano
G
G
López-Jurado
M
M
Nestares
T
T
Gomez
M C
MC
Mir
A
A
Ros
E
E
Mataix
J
J
Gil
A
A
D000368:Aged; D018592:Cross-Over Studies; D006801:Humans; D008077:Lipoproteins, LDL / Q000378:metabolism*; D008264:Macrophages / Q000187:drug effects / Q000378:metabolism; D008297:Male; D000069463:Olive Oil; D010084:Oxidation-Reduction / Q000187:drug effects; D010938:Plant Oils / Q000145:classification* / Q000494:pharmacology*; D014652:Vascular Diseases / Q000378:metabolism*
D008077:Lipoproteins, LDL; D000069463:Olive Oil; D010938:Plant Oils